Treatment with Gal‐3 increased the expression of PD‐L1 in A549 lung cancer cells as well as STAT3 phosphorylation, whereas blocking Gal‐3 with an inhibitor decreased both the expression of PD‐L1 and STAT3 phosphorylation in these cells (Fig. 2A). Here, LGALS3 is linked to lung cancer.